Tolerogenic dendritic cells and regulatory T cells: A two-way relationship

Journal of Dermatological Science

Volumn 46, Issue 3, 2007, Pages 159-167

  Mahnke, Karsten ^a   Johnson, Theron S ^a   Ring, Sabine ^a   Enk, Alexander H ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Dendritic cells; Regulatory T cells; Tolerance

Indexed keywords

CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STEADY STATE;

ANTIGENS, CD4; APOPTOSIS; CELL COMMUNICATION; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 34247177494     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.03.002     Document Type: Review

References (59)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Schuler G., and Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161 (1985) 526-546
3. Mahnke K., Schmitt E., Bonifaz L., Enk A.H., and Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80 (2002) 477-483
4. Mahnke K., Knop J., and Enk A.H. Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol 24 (2003) 646-651
5. Jonuleit H., Schmitt E., Schuler G., Knop J., and Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
6. Holmen N., Lundgren A., Lundin S., Bergin A.M., Rudin A., Sjovall H., et al. Functional CD4+ CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 12 (2006) 447-456
7. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193 (2001) 1285-1294
8. Nilsson J., Boasso A., Velilla P.A., Zhang R., Vaccari M., Franchini G., et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108 (2006) 3808-3817
9. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 116 (2006) 1713-1722
10. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
11. Mottet C., Uhlig H., and Powrie F. Cutting edge: cure of colitis by CD4+ CD25+ regulatory T cells. J Immunol 170 (2003) 3939-3943
12. Lindley S., Dayan C.M., Bishop A., and Roep B.O. Peakman MTree TI: defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
13. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212 (2006) 217-237
14. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151 (2000) 673-684
15. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194 (2001) 769-779
16. Mahnke K., Qian Y., Knop J., and Enk A.H. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101 (2003) 4862-4869
17. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8 + T cell tolerance. J Exp Med 196 (2002) 1627-1638
18. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 (2005) 1219-1227
19. Hawiger D., Masilamani R.F., Bettelli E., Kuchroo V.K., and Nussenzweig M.C. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20 (2004) 695-705
20. Bruder D., Westendorf A.M., Hansen W., Prettin S., Gruber A.D., Qian Y., et al. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54 (2005) 3395-3401
21. Muller G., Muller A., Tuting T., Steinbrink K., Saloga J., Szalma C., et al. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J Invest Dermatol 119 (2002) 836-841
22. Steinbrink K., Graulich E., Kubsch S., Knop J., and Enk A.H. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99 (2002) 2468-2476
23. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
24. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195 (2002) 15-21
25. van Lieshout A.W., Barrera P., Smeets R.L., Pesman G.J., van Riel P.L., van den Berg W.B., et al. Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis. Ann Rheum Dis 64 (2005) 408-414
26. Wang Q., Liu Y., Wang J., Ding G., Zhang W., Chen G., et al. Induction of allospecific tolerance by immature dendritic cells genetically modified to express soluble TNF receptor. J Immunol 177 (2006) 2175-2185
27. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., and Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98 (2001) 6800-6805
28. Inaba K., Turley S., Iyoda T., Yamaide F., Shimoyama S., Reis e Sousa, et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 191 (2000) 927-936
29. Harshyne L.A., Watkins S.C., Gambotto A., and Barratt-Boyes S.M. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 166 (2001) 3717-3723
30. Thery C., Duban L., Segura E., Veron P., Lantz O., and Amigorena S. Indirect activation of naive CD4 + T cells by dendritic cell-derived exosomes. Nat Immunol 3 (2002) 1156-1162
31. Henri S., Vremec D., Kamath A., Waithman J., Williams S., Benoist C., et al. The dendritic cell populations of mouse lymph nodes. J Immunol 167 (2001) 741-748
32. Holt P.G., Schon-Hegrad M.A., Oliver J., Holt B.J., and McMenamin P.G. A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol 91 (1990) 155-159
33. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191 (2000) 435-444
34. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188 (1998) 2163-2173
35. Urban B.C., Willcox N., and Roberts D.J. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA 98 (2001) 8750-8755
36. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O., et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196 (2002) 1553-1561
37. Mehling A., Loser K., Varga G., Metze D., Luger T.A., Schwarz T., et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194 (2001) 615-628
38. Blanco P., Palucka A.K., Gill M., Pascual V., and Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 (2001) 1540-1543
39. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van K.C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180 (1994) 1263-1272
40. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C.R., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28 (1998) 2760-2769
41. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12 (1994) 991-1045
42. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
43. Blander J.M., and Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol 7 (2006) 1029-1035
44. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
45. Lim H.W., Hillsamer P., Banham A.H., and Kim C.H. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175 (2005) 4180-4183
46. Cederbom L., Hall H., and Ivars F. CD4+ CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30 (2000) 1538-1543
47. Misra N., Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., and Kaveri S.V. Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 172 (2004) 4676-4680
48. Houot R., Perrot I., Garcia E., and Durand ILebecque S. Human CD4+ CD25 high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J Immunol 176 (2006) 5293-5298
49. Veldhoen M., Moncrieffe H., Hocking R.J., Atkins C.J., and Stockinger B. Modulation of dendritic cell function by naive and regulatory CD4 + T cells. J Immunol 176 (2006) 6202-6210
50. Akbari O., DeKruyff R.H., and Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2 (2001) 725-731
51. Kryczek I., Wei S., Zou L., Zhu G., Mottram P., Xu H., et al. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177 (2006) 40-44
52. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548 515-48
53. Lewkowich I.P., Herman N.S., Schleifer K.W., Dance M.P., Chen B.L., Dienger K.M., et al. CD4+ CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 202 (2005) 1549-1561
54. Serra P., Amrani A., Yamanouchi J., Han B., Thiessen S., Utsugi T., et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+ CD25+ T cells. Immunity 19 (2003) 877-889
55. Ghiringhelli F., Puig P.E., Roux S., Parcellier A., Schmitt E., Solary E., et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+ CD25+ regulatory T cell proliferation. J Exp Med 202 (2005) 919-929
56. Larmonier N., Marron M., Zeng Y., Cantrell J., Romanoski A., Sepassi M., et al. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 56 (2007) 48-59
57. Steinbrink K., Wolfl M., Jonuleit H., Knop J., and Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159 (1997) 4772-4780
58. Tadokoro C.E., Shakhar G., Shen S., Ding Y., Lino A.C., Maraver A., et al. Regulatory T cells inhibit stable contacts between CD4 + T cells and dendritic cells in vivo. J Exp Med 203 (2006) 505-511
59. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7 (2006) 83-92